Results 121 to 130 of about 3,757,704 (310)
Pre-eclampsia: Praxis and application
, 2018 Pre-eclampsia occurs in approximately 2-8% of pregnancies worldwide, and is characterised by hypertension and multi-organ system involvement. Globally, approximately ten million women develop pre-eclampsia each year, and an estimated 76 000 women die as
Taela Stokes, Sadie Geraghty
core +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Objective To identify the risk factors for intrapartum stillbirth and examine whether these are different from that of antepartum stillbirth, and investigate the survival probabilities of fetuses by gestational age in high‐risk pregnancies. Methods We conducted a secondary data analysis of a hospital‐based cohort study from India, including ...
Yebeen Ysabelle Boo +21 more
wiley +1 more source
Trends and indications for cesarean section in the ORIGINS birth cohort
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Objective Cesarean section (CS) rates have increased substantially in Australia, with particularly high use observed in private maternity care and for pre‐labor CS. The aim of the present study was to describe the CS rates and the clinical indications for pre‐labor CS in the ORIGINS birth cohort.
Kristjana Einarsdottir +6 more
wiley +1 more source
Studies on plasma fibrinogen level in pre-eclampsia and eclampsia
, 1978 The plasma fibrinogen level of maternal blood has been estimated in 30 cases of pre-eclampsia, 60 cases of eclampsia and 35 cases of normal pregnancy of 3rd trimester.
Chakravarty, T. +7 more
core +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Objective To explore the different patterns in early‐pregnancy mean arterial pressure (MAP) trajectories before 20 weeks of gestation in pregnant women with chronic hypertension, and whether it can stratify risk for adverse perinatal outcomes.
Haoyu Zuo +4 more
wiley +1 more source
Acta Obstetricia et Gynecologica ScandinavicaIntroduction Eclampsia is a life‐threatening complication of pre‐eclampsia. There are currently no means of reliably identifying women with pre‐eclampsia who are at the highest risk of progression to eclampsia and would thus benefit from prioritization ...
Annettee Nakimuli +9 more
doaj +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Integrated approach to menopausal hormone therapy in women with cardiovascular risk factors or established ischemic heart disease, from early treatment initiation and risk stratification to individualized therapy, multidisciplinary follow‐up, and health‐system recommendations.
Chiara Benedetto +9 more
wiley +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract For six decades, pregnant women have been routinely excluded from pharmaceutical clinical trials, a practice rooted in a protectionist ethic that emerged after the thalidomide tragedy. This narrative review examines whether that exclusion remains ethically justifiable, drawing on the obstetric, pharmacological, and bioethical literature ...
Camila Kruger Cabar +1 more
wiley +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Lynch syndrome and BRCA‐mutation associated malignancies are fortunately rare. Affected patients have an increased risk of cancer diagnosis at a young age, often significantly overlapping with their reproductive years. In helping these patients, oncologists must navigate the following areas of care: cancer prevention, impact of cancer ...
Anna Weimer +20 more
wiley +1 more source
Vascular cell adhesion molecule-1 (VCAM-1) and leukocyte activation in pre-eclampsia and eclampsia
, 1998 Objective: To evaluate the levels of VCAM-1 in pre-eclampsia/eclampsia as a possible marker of leukocyte activation and endothelial damage. Methods: We performed a case-control study on 25 healthy pregnant women and 35 patients diagnosed as pre-eclampsia
E Budak +16 more
core +1 more source